{
    "2020-12-08": [
        [
            {
                "time": "2020-12-08",
                "original_text": "Wind快讯 | 每日医药行业动态（2020-12-08）",
                "features": {
                    "keywords": [
                        "医药",
                        "行业动态",
                        "Wind"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "异动股】泰格医药(03347-HK)涨3.22%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "涨",
                        "异动股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本概念股再度活跃，金域医学、广联达、国瓷材料、泰格医药等普涨",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "普涨",
                        "泰格医药",
                        "金域医学"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "西南证券：浪潮之巅 中国创新药迎来黄金时期",
                "features": {
                    "keywords": [
                        "西南证券",
                        "创新药",
                        "黄金时期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物暂停子公司转让 战略方向不变背后加码新冠疫苗",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "子公司转让",
                        "新冠疫苗"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "居然是一个逻辑：沃森生物持续下跌、茅台不断创历史新高",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "下跌",
                        "茅台",
                        "新高"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "国君医药 | 2021年度策略：需求无止境，供给共繁荣",
                "features": {
                    "keywords": [
                        "国君医药",
                        "年度策略",
                        "需求",
                        "供给"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物71亿隐秘野心，李云春为何弃泽润如鸡肋？",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "71亿",
                        "野心",
                        "李云春",
                        "泽润"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2021年度投资策略：需求无止境 供给共繁荣",
                "features": {
                    "keywords": [
                        "医药行业",
                        "年度投资策略",
                        "需求",
                        "供给"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2020年12月投资月报：医药反弹持续性如何？",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资月报",
                        "反弹",
                        "持续性"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森“贱卖”核心子公司一夜反转！泰格“捡漏”、或为泽润上市铺路 管理层承压转让计划暂落空",
                "features": {
                    "keywords": [
                        "沃森",
                        "贱卖",
                        "核心子公司",
                        "泰格",
                        "捡漏",
                        "泽润",
                        "上市",
                        "管理层承压"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}